Over-expression of talin 1 and integrin-linked kinase in PBMCs of patients with ankylosing spondylitis: A proteomic study

Clinical and Experimental Rheumatology

Volumn 28, Issue 6, 2010, Pages 828-835

  Li, T ^a   Zheng, B ^a   Huang, Z ^a   Lu, H ^a   Lin, Q ^a   Liao, Z ^a   Lin, Z ^a   Zhao, L ^b   Wang, X ^a   Gu, J ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Ankylosing spondylitis; Integrin linked kinase; Mass spectrometry; Talin 1; Two dimensional electrophoresis

Indexed keywords

BIOLOGICAL MARKER; CHAIN A OF CYCLOPHILIN A; INTEGRIN; INTEGRIN LINKED KINASE; PROFILIN I; PROTEIN; PYRUVATE KINASE; TALIN 1; UNCLASSIFIED DRUG; INTEGRIN-LINKED KINASE; PROTEIN SERINE THREONINE KINASE; TALIN; TLN1 PROTEIN, HUMAN;

ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; MASS SPECTROMETRY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEOMICS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL ELECTROPHORESIS; VALIDATION STUDY; WESTERN BLOTTING; ADULT; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; SPONDYLITIS, ANKYLOSING; TALIN;

EID: 79952691523     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. MADER R: Atypical clinical presentation of ankylosing spondylitis. Semin Arthritis Rheum 1999; 29: 191-6.
2. VAN DER HORST-BRUINSMA IE, LEMS WF, DIJKMANS BA: A systematic comparison of rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009; 27 (Suppl. 55): S43-S9.
3. LANDEWÉ R, VAN DER HEIJDE D: A systematic comparison of rheumatoid arthritis and ankylosing spondylitis: structural outcomes. Clin Exp Rheumatol 2009; 27 (Suppl. 55): S 102-S7.
4. BRAUN J, SIEPER J: Classification criteria for rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009; 27 (Suppl. 55): S68-S73.
5. BLUM U, BUITRAGO-TELLEZ C, MUNDINGER A et al.: Magnetic resonance imaging (MRI) for detection of active sacroiliitis-a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI. J Rheumatol 1996; 23: 2107-15.
6. Brown MA, Kennedy LG, Macgregor AJ et al.: Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997; 40: 1823-8. (Pubitemid 27452533)
7. BREWERTON DA, HART FD, NICHOLLS A, CAFFREY M, JAMES DC, STURROCK RD: Ankylosing spondylitis and HL-A27. Lancet 1973; 1: 904-7.
8. SCHLOSSTEIN L, TERASAKI PI, BLUESTONE R, PEARSON CM: High association of an HLA antigen, W27, with ankylosing spondylites. N Engl J Med 1973; 288: 704-6.
9. LAVAL SH, TIMMS A, EDWARDS S et al.: Whole-genome screening in ankylosing spondylitis: evidence of non-MHC geneticsusceptibility loci. Am J Hum Genet 2001; 68: 918-26.
10. Brown MA, Pile KD, Kennedy LG et al.: A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 1998; 41: 588-95. (Pubitemid 28214976)
11. BROWN MA, CRANE AM, WORDSWORTH BP: Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis. Curr Opin Rheumatol 2002; 14: 354-60.
12. Maksymowych WP, Brown MA: Genetics of ankylosing spondylitis and rheumatoid arthritis: where are we at currently, and how do they compare? Clin Exp Rheumatol 2009; 27 (Suppl. 55): S20-S5.
13. TEUNISSEN CE, SCHELTENS P: Use of proteomic approaches to identify disease biomarkers. Lancet Neurol 2007; 6: 1036-7.
14. WOUTERS BG: Proteomics: methodologies and applications in oncology. Semin Radiât Oncol 2008; 18: 115-25.
15. GIUSTI L, BALDINI C, BAZZICHI L, BOMBARDIERI S, LUCACCHINI A: Proteomic diagnosis of Sjogren's syndrome. Exp Rev Proteomics 2007; 4: 757-67.
16. BALDINI C, GIUSTI L, BAZZICHI L et al.: Association of psoriasin (S 100A7) with clinical manifestations of systemic sclerosis: is its presence in whole saliva a potential predictor of pulmonary involvement? J Rheumatol 2008; 35: 1820-4.
17. BAZZICHI L, CIREGIA F, GIUSTI L et al:. Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteomics Clin Appl 2009; 3: 1296-304.
18. Li TW, Zheng BR, Huang ZX et al.: Screening disease-associated proteins from sera of patients with rheumatoid arthritis: a comparative proteomic study. Chin Med J (Engl) 2010; 123: 537-43.
19. LIU J, ZHU P, PENG J et al: Identification of disease-associated proteins by proteomic approach in ankylosing spondylitis. Biochem Biophys Res Commun 2007; 357: 531-6.
20. WÂLLBERG-JONSSON S, CAIDAHL K. KLINTLAND N, NYBERG G, RANTAPÄÄDAHLQVIST S: Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis. Scand J Rheumatol 2008; 37: 1-5.
21. MARCHI N, MAZZONE P, FAZIO V. MEKHAIL T, MASARYK T, JANIGRO D: ProApolipoprotein A1 : a serum marker of brain metastases in lung cancer patients. Cancer 2008; 112: 1313-24.
22. HOAGLAND LF4TH, CAMPA MJ, GOTTLINEB, HERNDON JE 2ND, PATZ EF JR: Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer. Cancer 2007; 110: 2260-8.
23. WRIGHT C, EDELMANN M, DI GLERIA K et al.: Ankylosing spondylitis monocytes show upregulation of proteins involved in inflammation and the ubiquitin proteasome pathway. Ann Rheum Dis 2009; 68: 1626-32.
24. LI T, HUANG Z, ZHENG B, LIAO Z, ZHAO L, GU J: Serum disease-associated proteins of ankylosing spondylitis: results of a prelimi-nary study by comparative proteomics. Clin Exp Rheumatol 2010; 28: 201-7.
25. Tan X, Cai D, Wu Y et al:. Comparative analysis of serum proteomes: discovery of proteins associated with osteonecrosis of the femoral head. Transi Res 2006; 148: 114-9. (Pubitemid 44287638)
26. Tadokoro S, Shattil SJ, Eto K et al.: Talin binding to integrin beta tails: a final common step in integrin activation. Science 2003; 302: 103-6. (Pubitemid 37210697)
27. LARJAVA H, PLOW EF, WU C: Kindlins: essential regulators of integrin signalling and cell-matrix adhesion. EMBO Rep 2008; 9: 1203-8.
28. LEGATE KR, MONTAÑEZ E, KUDLACEK O, FÄSSLER R: ILK, PINCH and parvin: the tIPP of integrin signaling. Nat Rev Mol Cell Bio 2006; 7: 20-31.
29. KIM TH, UHM WS, INMAN RD: Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 2005; 17: 400-5.
30. SCHULZ M, DOTZLAW H, MIKKAT S, EGGERT M, NEECK G: Proteomic analysis of peripheral blood mononuclear cells: selective protein processing observed in patients with rheumatoid arthritis. J Proteome Res 2007; 6: 3752-9.
31. GU J, MÄRKER-HERMANN E, BAETEN D et al:. A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. Rheumatology (Oxford) 2002; 41: 759-66.
32. GIANCOTTI FG: Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol 1997; 9: 691-700.
33. DEBRAND E, EL JAI Y, SPENCE L et al.: Talin 2 is a large and complex gene encoding multiple transcripts and protein isoforms. FEBS J 2009; 276: 1610-28.
34. ONOM, MURAKAMI T, TOMITAM, ISHIKAWA H: Association of the actin cytoskeleton with glass-adherent proteins in mouse peritoneal macrophages. Biol Cell 1993; 77: 219-30.
35. Somersalo K, Anikeeva N, Sims TN et al: Cytotoxic T lymphocytes form an antigen-independent ring junction. J Clin Invest 2004; 113: 49-57. (Pubitemid 38541631)
36. TIDBALL JG, OHALLORAN T, BURRlDGE K: Talin at myotendinous junctions. J Cell Biol 1986; 103: 1465-72.
37. FRENETTE J, TIDBALL JG: Mechanical loading regulates expression of talin and its mRNA, which are concentrated at myotendinous junctions. Am J Physiol 1998; 275: C818-25.
38. CAMPBELL ID, GINSBERG MH: The talintail interaction places integrin activation on FERM ground. Trends Biochem Sci 2004; 29: 429-35.
39. MANEVICH E, GRABOVSKY V, FEIGELSON SW, ALON R: Talin 1 and paxillin facilitate distinct steps in rapid VLA-4-mediated adhesion strengthening to vascular cell adhesion molecule 1. J Biol Chem 2007; 282: 25338-48.
40. FRIEDRICH EB, SINHA S, LI L et al.: Role of integrin-linked kinase in leukocyte recruitment. J Biol Chem 2002; 277: 16371-5.
41. TAN C, MUI A, DEDHAR S: Integrin-linked kinase regulates inducible nitric oxide synthase and cyclooxygenase-2 expression in an NF-kappa B-dependent manner. J Biol Chem 2002; 277: 3109-16.
42. GKRETSI V, MARS WM, BOWEN WC et al:. Loss of integrin linked kinase from mouse hepatocytes in vitro and in vivo results in apoptosis and hepatitis. Hepatology 2007; 45: 1025-34.
43. HOSS JE, ARABIAN A, DEDHAR S, ST. ARNAUD R: Inactivation of the integrin-linked kinase (ILK) in osteoblasts increases mineralization. Bone 2008; 42: S20-21.
44. TANAKA Y: Integrin activation by chemokines: relevance to inflammatory adhesion cascade during T cell migration. Histol Histopathol 2000; 15: 1169-76.
45. Kim H, Kim WJ, Jeon ST et al.: Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages. Clin Immunol 2005; 116: 217-24. (Pubitemid 41112725)
46. KANSY JW, KATSOVlCH L, MCIVER KS et al.: Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol 2006; 181: 165-76.